Research programme: cartilage growth factor receptors - Regeneron
Alternative Names: Cartilage growth factor receptors research programme - RegeneronLatest Information Update: 28 Jun 2006
At a glance
- Originator Regeneron Pharmaceuticals
- Class
- Mechanism of Action Intercellular signalling peptide and protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis
Most Recent Events
- 11 Jul 2000 New profile
- 11 Jul 2000 Preclinical development for Osteoarthritis in USA (Unknown route)